43 results on '"Spirito, Alessandro"'
Search Results
2. Ticagrelor with or without aspirin following percutaneous coronary intervention in high-risk patients with concomitant peripheral artery disease: A subgroup analysis of the TWILIGHT randomized clinical trial
3. Real-World Comparison of Clopidogrel With Ticagrelor and Prasugrel in Patients With Chronic Coronary Disease Who Underwent Atherectomy
4. 1- Versus 3-Month DAPT in Older Patients at a High Bleeding Risk Undergoing PCI: Insights from the XIENCE Short DAPT Global Program
5. Prognostic impact of pre-frailty and frailty in women undergoing TAVR: Insights from the WIN-TAVI Registry
6. Significance of Kidney Disease in Cardiovascular Disease Patients
7. 1- or 3-Month DAPT in Patients With HBR With or Without Oral Anticoagulant Therapy After PCI
8. Bleeding and Ischemic Risks of Ticagrelor Monotherapy After Coronary Interventions
9. LB-10 | Predictive Value of the Thrombotic Risk Criteria of the 2020 ESC guidelines for NSTE-ACS: Validation in a Large PCI Registry
10. LB-9 | Repeated Coronary Revascularization in High-Risk Patients Treated With Ticagrelor Monotherapy After PCI: Insights from the Randomized TWILIGHT Trial
11. PROGNOSTIC VALUE OF HIGH-SENSITIVITY C-REATIVE PROTEIN AMONG CHRONIC KIDNEY DISEASE PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION
12. A-28 | Prognostic Impact of Blood Glucose Level in Patients Undergoing PCI
13. B-6 | Prognostic Impact of Procedural Complexity in Octogenarians Undergoing Percutaneous Coronary Intervention
14. Validation of UK-BCIS CHIP Score to Predict 1-Year Outcomes in a Contemporary United States Population
15. Fatal, ischemic and bleeding risk of patients meeting the selection criteria of the TWILIGHT trial: insights from a large PCI registry.
16. Biolimus-eluting vs. other limus-eluting stents in NSTE-ACS: A pooled analysis of glassy and twilight
17. Outcomes in Patients With Early Menopause Who Underwent Transcatheter Aortic Valve Implantation
18. ONE VERSUS THREE MONTH DAPT IN HIGH BLEEDING RISK PATIENTS WITH OR WITHOUT CHRONIC KIDNEY DISEASE: RESULTS FROM THE XIENCE SHORT DAPT GLOBAL PROGRAM
19. IMPACT OF SEX ON OUTCOMES AMONG PATIENTS WITH A PREVIOUS CORONARY ARTERY BYPASS GRAFT UNDERGOING PERCUTANEOUS CORONARY INTERVENTION
20. ONE- VERSUS THREE-MONTH DAPT IN OLDER PATIENTS AT HIGH BLEEDING RISK UNDERGOING PCI: INSIGHTS FROM THE XIENCE SHORT DAPT GLOBAL PROGRAM
21. IMPACT OF BODY SURFACE AREA ON OUTCOMES IN WOMEN AND MEN UNDERGOING PERCUTANEOUS CORONARY INTERVENTION
22. SEX-SPECIFIC PREDICTORS OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH PREMATURE CORONARY ARTERY DISEASE UNDERGOING PERCUTANEOUS CORONARY INTERVENTION
23. Sex Differences Among Patients Receiving Edoxaban vs Vitamin K Antagonist for Atrial Fibrillation After TAVR
24. New Criteria to Identify Patients at Higher Risk for Cardiovascular Complications After Percutaneous Coronary Intervention
25. Impact of design characteristics among studies comparing coronary computed tomography angiography to noninvasive functional testing in chronic coronary syndromes
26. Acute Coronary Occlusion in Patients With Non-ST-Segment Elevation Out-of-Hospital Cardiac Arrest
27. The mega COMBO collaboration: An individual patient data pooled analysis of patients undergoing PCI with COMBO stent
28. Recent Advances in Antiplatelet Therapy in Complex Percutaneous Coronary Intervention
29. Depression and ischemic heart disease
30. TCT-4 Dual Antiplatelet Therapy for 1 Versus 3 Months in Women and Men at High Bleeding Risk Undergoing Drug-Eluting Stent Implantation
31. TCT-13 Ticagrelor Monotherapy in Patients With Peripheral Artery Disease Undergoing PCI
32. TCT-8 Frequency, Predictors, and Impact of Acute Coronary Occlusion in Patients With Out-of-Hospital Cardiac Arrest and Non–ST-Segment Elevation
33. Comparative Outcomes After Percutaneous Coronary Intervention in Unconscious and Conscious Patients With Out-of-Hospital Cardiac Arrest
34. Impact of Small Valve Size on 1-Year Outcomes After Transcatheter Aortic Valve Implantation in Women (from the WIN-TAVI Registry)
35. C-57 | Prevalence and Outcomes of Early Menopause in Women undergoing Transcatheter Aortic Valve Replacement: Insights from the WIN-TAVI Registry
36. A-54 | Efficacy and Safety of P2Y12 Inhibitor Monotherapy After Complex PCI: A Collaborative Systematic Review and Meta-Analysis
37. Impact of Chronic Kidney Disease on Periprocedural Anticoagulation and Short-Term Outcomes after TAVR: A BRAVO-3 Trial Subanalysis
38. Lugar de acceso y tipo de anticoagulante en pacientes con síndrome coronario agudo en clase Killip avanzada o con parada cardiaca extrahospitalaria
39. Choice of access site and type of anticoagulant in acute coronary syndromes with advanced Killip class or out-of-hospital cardiac arrest
40. Impact of Left Ventricular Outflow Tract Calcification on Procedural Outcomes After Transcatheter Aortic Valve Replacement
41. Subcutaneous Selatogrel Inhibits Platelet Aggregation in Patients With Acute Myocardial Infarction
42. Edge-to-Edge Mitral Valve Repair With Extended Clip Arms
43. Choice of access site and type of anticoagulant in acute coronary syndromes with advanced Killip class or out-of-hospital cardiac arrest
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.